[1]
Ayesha et al. 2023. Human epidermal growth factor receptor 2 (Her2/Neu) immunoexpression in gastrointestinal adenocarcinomas: A clinicopathological study. Journal of Population Therapeutics and Clinical Pharmacology. 30, 15 (Jun. 2023), 465–474. DOI:https://doi.org/10.47750/jptcp.2023.30.15.053.